Type
1.
de Oliveira JA da P, de Athaide MM, Rahman AU, Barbosa MG de M, Jardim MM, Moraes MO, et al. Kynurenines in the Pathogenesis of Peripheral Neuropathy During Leprosy and COVID-19. Frontiers in cellular and infection microbiology [Internet]. 2022;12:815738. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907883/pdf/fcimb-12-815738.pdf
Type
1.
Muldoon OT, Jay S Centre for Social Issues Research University of Limerick Castletroy Ireland, O’Donnell AT, Winterburn M, Moynihan AB, O’Connell BH Centre for Social Issues Research University of Limerick Castletroy Ireland, Department of Psychology Maynooth University Maynooth Ireland, et al. Health literacy among self-help leprosy group members reduces stereotype endorsement and stigma-related harm in rural Nepal. Health & social care in the community [Internet]. 2022; Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1111/hsc.13771
Type
1.
Oktaria S, Anfasa F, Menaldi SL, Bramono K, Nijsten TEC, Thio HB. Serum Interleukin 6 Level and Nutrition Status as Potential Predictors of Clinical Leprosy Development Among Household Contacts in Endemic Areas. Open forum infectious diseases [Internet]. 2022;9(3):ofac010. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883588/pdf/ofac010.pdf
Type
1.
Machado LMG, dos Santos ES Teacher Education and Postgraduate Studies, Federal University of Mato Grosso, Brazil, Cavaliero A, Steinmann P, Ignotti E Universidade do Estado de Mato Grosso, Brazil; Universidade Federal de Mato Grosso, Brazil. Spatio-temporal analysis of leprosy risks in a municipality in the state of Mato Grosso-Brazilian Amazon: results from the leprosy post-exposure prophylaxis program in Brazil. Infectious diseases of poverty [Internet]. 2022;11(1):21. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862266/pdf/40249_2022_Article_943.pdf
Type
1.
Jones D, CA J, Joshi A, AS S, Kumar H. Deep Vein Thrombosis in Lepromatous Leprosy: A Case Report of Secondary Pediatric Antiphospholipid Syndrome. Cureus [Internet]. 2022;14(1):e21361. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853942/pdf/cureus-0014-00000021361.pdf
Type
1.
Vera-Cabrera L, Ramos-Cavazos CJ, Youssef NA, Pearce CM, Molina-Torres CA, Avalos-Ramirez R, et al. Mycobacterium leprae Infection in a Wild Nine-Banded Armadillo, Nuevo León, Mexico. Emerging infectious diseases [Internet]. 2022;28(3):747-9. Available from: https://wwwnc.cdc.gov/eid/article/28/3/pdfs/21-1295-combined.pdf
Type
1.
Lahiri R, Adams LB, Thomas SS, Pethe K. Sensitivity of Mycobacterium leprae to Telacebec. Emerging infectious diseases [Internet]. 2022;28(3):749-51. Available from: https://wwwnc.cdc.gov/eid/article/28/3/pdfs/21-0394.pdf
Type
1.
Bhattacharya M, Sharma AR, Ghosh P, Patra P, Mallick B, Patra BC, et al. TN strain proteome mediated therapeutic target mapping and multi-epitopic peptide-based vaccine development for Mycobacterium leprae. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases [Internet]. 2022;99:105245. Available from: https://www.sciencedirect.com/science/article/pii/S1567134822000429?via%3Dihub
Type
1.
Saini C, Sapra L, Bhardwaj A, Tarique M, Sharma A, Khanna N, et al. IL-21 plays an important role in modulating "Th17-Treg" cell axis in leprosy Type 1 reactions. Cytokine. 2022;152:155821.
Type
1.
Marçal PHF, De Souza MLM, Gama RS, de Oliveira LBP, Gomes M de S, Amaral LR do, et al. Algorithm Design for a Cytokine Release Assay of Antigen-Specific In Vitro Stimuli of Circulating Leukocytes to Classify Leprosy Patients and Household Contacts. Open forum infectious diseases [Internet]. 2022;9(3):ofac036. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842339/pdf/ofac036.pdf
Pagination
- Previous page
- Page 31
- Next page